8009-8341 Screening compound: N-(2-{[(cyclohexylcarbamoyl)methyl]sulfanyl}-1,3-benzothiazol-6-yl)-2-({4-methyl-5-[(naphthalen-1-yl)methyl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide

8009-8341 Screening compound: N-(2-{[(cyclohexylcarbamoyl)methyl]sulfanyl}-1,3-benzothiazol-6-yl)-2-({4-methyl-5-[(naphthalen-1-yl)methyl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide
8009-8341 Screening compound: N-(2-{[(cyclohexylcarbamoyl)methyl]sulfanyl}-1,3-benzothiazol-6-yl)-2-({4-methyl-5-[(naphthalen-1-yl)methyl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 8009-8341
N-(2-{[(cyclohexylcarbamoyl)methyl]sulfanyl}-1,3-benzothiazol-6-yl)-2-({4-methyl-5-[(naphthalen-1-yl)methyl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

8009-8341

Molecular Formula

C31H32N6O2S3 (C31 H32 N6 O2 S3)

Compound Name

N-(2-{[(cyclohexylcarbamoyl)methyl]sulfanyl}-1,3-benzothiazol-6-yl)-2-({4-methyl-5-[(naphthalen-1-yl)methyl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide

IUPAC name

N-(2-{[(cyclohexylcarbamoyl)methyl]sulfanyl}-13-benzothiazol-6-yl)-2-({4-methyl-5-[(naphthalen-1-yl)methyl]-4H-124-triazol-3-yl}sulfanyl)acetamide

SMILES

Cn1c(SCC(Nc(cc2)cc3c2nc(SCC(NC2CCCCC2)=O)s3)=O)nnc1Cc1cccc2ccccc12

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

616.83

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

6.047

Distribution Coefficient, logD

6.047

Water Solubility, LogSw

-6.59

Polar Surface Area

81.912

Acid Dissociation Constant (pKa)

11.85

Base Dissociation Constant (pKb)

3.09

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.30

8009-8341 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Lipid Metabolism Library (9174 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with 8009-8341 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 8009-8341?
Check Price and Availability of 8009-8341, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 8009-8341 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 8009-8341
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 8009-8341
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 8009-8341 available by request